Literature DB >> 26278498

A de-novo interstitial microduplication involving 2p16.1-p15 and mirroring 2p16.1-p15 microdeletion syndrome: Clinical and molecular analysis.

Aviva Mimouni-Bloch1, Josepha Yeshaya2, Sarit Kahana3, Idit Maya4, Lina Basel-Vanagaite5.   

Abstract

BACKGROUND: Microdeletions of various sizes in the 2p16.1-p15 chromosomal region have been grouped together under the 2p16.1-p15 microdeletion syndrome. Children with this syndrome generally share certain features including microcephaly, developmental delay, facial dysmorphism, urogenital and skeletal abnormalities. We present a child with a de-novo interstitial 1665 kb duplication of 2p16.1-p15. METHODS AND
RESULTS: Clinical features of this child are distinct from those of children with the 2p16.1-p15 microdeletion syndrome, specifically the head circumference which is within the normal range and mild intellectual disability with absence of autistic behaviors. Microduplications many times bear milder clinical phenotypes in comparison with corresponding microdeletion syndromes. Indeed, as compared to the microdeletion syndrome patients, the 2p16.1-p15 microduplication seems to have a milder cognitive effect and no effect on other body systems. Limited information available in genetic databases about cases with overlapping duplications indicates that they all have abnormal developmental phenotypes.
CONCLUSION: The involvement of genes in this location including BCL11A, USP34 and PEX13, affecting fundamental developmental processes both within and outside the nervous system may explain the clinical features of the individual described in this report.
Copyright © 2015 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  2p microdeletion syndrome; Chromosome 2; Developmental delay; Microduplication

Mesh:

Substances:

Year:  2015        PMID: 26278498     DOI: 10.1016/j.ejpn.2015.07.013

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  5 in total

1.  Identifying candidate genes for 2p15p16.1 microdeletion syndrome using clinical, genomic, and functional analysis.

Authors:  Hani Bagheri; Chansonette Badduke; Ying Qiao; Rita Colnaghi; Iga Abramowicz; Diana Alcantara; Christopher Dunham; Jiadi Wen; Robert S Wildin; Malgorzata Jm Nowaczyk; Jennifer Eichmeyer; Anna Lehman; Bruno Maranda; Sally Martell; Xianghong Shan; Suzanne Me Lewis; Mark O'Driscoll; Cheryl Y Gregory-Evans; Evica Rajcan-Separovic
Journal:  JCI Insight       Date:  2016-03-17

Review 2.  MOLECULAR MEDICINE: Found in Translation.

Authors:  Stuart H Orkin
Journal:  Med (N Y)       Date:  2021-01-12

3.  NeuroSCORE is a genome-wide omics-based model that identifies candidate disease genes of the central nervous system.

Authors:  Kyle W Davis; Colleen G Bilancia; Megan Martin; Rena Vanzo; Megan Rimmasch; Yolanda Hom; Mohammed Uddin; Moises A Serrano
Journal:  Sci Rep       Date:  2022-03-31       Impact factor: 4.379

4.  Microduplication in the 2p16.1p15 chromosomal region linked to developmental delay and intellectual disability.

Authors:  Luca Lovrecic; Chiara Gnan; Federica Baldan; Alessandra Franzoni; Sara Bertok; Giuseppe Damante; Bertrand Isidor; Borut Peterlin
Journal:  Mol Cytogenet       Date:  2018-06-20       Impact factor: 2.009

5.  BCL11A: a potential diagnostic biomarker and therapeutic target in human diseases.

Authors:  Jiawei Yin; Xiaoli Xie; Yufu Ye; Lijuan Wang; Fengyuan Che
Journal:  Biosci Rep       Date:  2019-11-29       Impact factor: 3.840

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.